ECSP972184A - POLYNUCLEOTIDIC VACCINE INTENDED FOR CATTLE BY THE INTRADERMIC ROUTE - Google Patents

POLYNUCLEOTIDIC VACCINE INTENDED FOR CATTLE BY THE INTRADERMIC ROUTE

Info

Publication number
ECSP972184A
ECSP972184A ECSP972184A ECSP972184A EC SP972184 A ECSP972184 A EC SP972184A EC SP972184 A ECSP972184 A EC SP972184A EC SP972184 A ECSP972184 A EC SP972184A
Authority
EC
Ecuador
Prior art keywords
vaccine formula
bovine
polynucleotidic
cattle
immunogen
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Franciscus Antonius Rijsewijk
Remco Siebren Schrijver
Oirschot Johannes Theodorus Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972184 priority Critical patent/ECSP972184A/en
Publication of ECSP972184A publication Critical patent/ECSP972184A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La fórmula de vacuna bovina polimucleotídica comprende una cantidad eficaz por via intradérmica de un plásmido que asocia una secuencia de ADN que codifica para una inmunógeno de un agente patógeno bovino con un promotor que la expresión de este inmunógeno en vivo en las células de la piel, estando adaptada esta fórmula de vacuna a la administración intradérmica por un aparato de administración por chorro líquido. La instalación portátil de vacunación bovina comprende un aparato de administración por chorro líquido y un frasco adaptado que comprende varias dosis de esta fórmula de vacuna, estando diseñado el aparato de administración para suministrar una dosis de fórmula de vacuna por vía intradérmica.The polymucleotide bovine vaccine formula comprises an intradermally effective amount of a plasmid that associates a DNA sequence encoding an immunogen of a bovine pathogen with a promoter that expresses this immunogen in vivo in skin cells, this vaccine formula being adapted for intradermal administration by a liquid jet administration apparatus. The portable bovine vaccination facility comprises a liquid jet delivery apparatus and an adapted vial comprising various doses of this vaccine formula, the delivery apparatus being designed to deliver one dose of vaccine formula intradermally.

ECSP972184 1997-07-15 1997-07-15 POLYNUCLEOTIDIC VACCINE INTENDED FOR CATTLE BY THE INTRADERMIC ROUTE ECSP972184A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972184 ECSP972184A (en) 1997-07-15 1997-07-15 POLYNUCLEOTIDIC VACCINE INTENDED FOR CATTLE BY THE INTRADERMIC ROUTE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972184 ECSP972184A (en) 1997-07-15 1997-07-15 POLYNUCLEOTIDIC VACCINE INTENDED FOR CATTLE BY THE INTRADERMIC ROUTE

Publications (1)

Publication Number Publication Date
ECSP972184A true ECSP972184A (en) 1998-09-22

Family

ID=42043015

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972184 ECSP972184A (en) 1997-07-15 1997-07-15 POLYNUCLEOTIDIC VACCINE INTENDED FOR CATTLE BY THE INTRADERMIC ROUTE

Country Status (1)

Country Link
EC (1) ECSP972184A (en)

Similar Documents

Publication Publication Date Title
AR007863A1 (en) BOVINE VACCINE FORMULA, ITS USE AND PORTABLE BOVINE VACCINATION INSTALLATION
FI101632B1 (en) Process for the preparation of analogues to the subunit of Bordetella pertussis toxin and recombinant DNA molecules encoding these
DE60012711D1 (en) ADJUVAN COMPOSITIONS FOR INCREASING THE IMMUNE RESPONSE ON POLYNUCLEOTIDE-BASED VACCINES
AR044985A1 (en) IMMUNIZATION METHOD AND PATCH BY MICROPROJECTION PROVISION
MX9704550A (en) Aerosol drug formulations.
ES2133477T3 (en) DOSAGE FORM INCLUDING AN ANTIGEN AND A SALT FORM OF AN ORGANIC ACID DERIVATIVE OF A STEROL.
NO20021431L (en) Intranasal influenza virus vaccine
AR035586A1 (en) COMPOSITION OF VACCINE, EQUIPMENT, METHODS TO INCREASE THE IMMUNE RESPONSE, USE OF A DERIVATIVE OF 1H-IMIDAZO (4,5-C) QUINOLIN-4-AMINA IN THE MANUFACTURE OF A MEDICINAL PRODUCT, AND COMBINATION OF COMPONENTS FOR SEPARATE, SEQUENTIAL ADMINISTRATION OR CONCOMITANT FOR USE IN DNA VACCINATION
BR0209041A (en) Microprojection Array Immunization Plaster and Method
ATE433771T1 (en) DEVICE FOR DELIVERING A VACCINE
ES2098029T3 (en) HEPATITIS VACCINES CONTAINING 3-O-DESACLATED LIPIDO MONOFOSFORIL.
ES2103928T5 (en) MYCOBACTERIUM POLIPEPTIDES AND NUCLEIC ACIDS THAT CODIFY THEM USED IN THE DIAGNOSIS AND TUBERCULOSIS TREATMENT.
MX9709870A (en) In ovo vaccination against coccidiosis.
PT92838A (en) DISPENSING DEVICES POWERED BY HYDROGEL
ES2070866T3 (en) RECOMBINANT VACCINES AGAINST COCCIDIOSIS.
WO2005016239A3 (en) Molecules enhancing dermal delivery of influenza vaccines
ES2183486T3 (en) FORMULATIONS OF FSH AND FSH VARIANTS THAT INCLUDE BENCILIC ALCOHOL AS A PRESERVATIVE AGENT.
ES2144394T3 (en) RECOMBINANT POLYPEPTIDES AND PEPTIDES, NUCLEIC ACIDS THAT CODE THEM AND USE OF SUCH POLYPEPTIDES AND PEPTIDES FOR THE DIAGNOSIS OF TUBERCULOSIS.
ES2039209T3 (en) PHARMACEUTICAL AGENT CONTAINING A HUMAN GRANULOCYTIC COLONY STIMULATION FACTOR.
ES2187568T3 (en) LIVE VACCINE FOR THE TREATMENT OF TUMOR DISEASES.
ES2061647T3 (en) VACCINE AGAINST NEWCASTLE DISEASE VIRUS AND METHOD FOR THE APPLICATION OF THE SAME.
ES2069742T3 (en) PROTEIN OF FELINE CALICIVIRUS CAPSID AND NUCLEOTIDE SEQUENCE.
ES2069099T3 (en) RECOMBINANT VACCINE FOR PORCINE PLEURONEUMONIA.
ES2137172T3 (en) ANTITUMORAL VACCINES INCLUDING IL-6-TRANSFECTED CELLS.
CA2166718A1 (en) Vaccine method against swine dysentery